News tagged with pfizer
n-3 fatty acids no benefit for high-risk cardio patients
(HealthDay)—For patients with multiple cardiovascular risk factors or atherosclerotic vascular disease who have not had a myocardial infarction, daily treatment with n-3 fatty acids does not reduce cardiovascular ...
Cardiology
May 09, 2013 |
not rated yet |
0
Bashful? Buy the little blue pill online (Update)
Pfizer Inc., in a first for the drug industry, told The Associated Press that the drugmaker will begin selling its popular erectile dysfunction pill Viagra directly to patients on its website.
Medications
May 06, 2013 |
not rated yet |
0
Canada, Uganda test drug to treat brain disease
Canada is funding testing in Uganda of a popular off-patent antidepressant drug to fight a fungal brain disease that claims more than half a million lives in sub-Saharan Africa every year.
Medications
May 01, 2013 |
5 / 5 (2) |
0
Study reveals how the world's first drug for amyloid disease works
Scientists from The Scripps Research Institute and Pfizer Inc. have published a new study showing how a new drug called tafamidis (Vyndaqel) works. Tafamidis, approved for use in Europe and currently under ...
Medical research
May 29, 2012 |
5 / 5 (3) |
0
|
Genetic differences may influence sensitivity to pain, study finds
The study, published in PLOS Genetics on 20 December, adds to growing evidence that particular genes are involved in chronic pain and highlights this pathway as a potential target for more effective pain relief treatments for pa ...
Genetics
Dec 20, 2012 |
5 / 5 (1) |
1
|
Faulty gene connected to ovarian cancer risk
In a new study published in Nature Genetics researchers say that women who possess a fault in a gene named RAD51D have a greater risk of developing ovarian cancer than women who do not have this fault and tests are expect ...
Cancer
Aug 09, 2011 |
not rated yet |
0
|
Clinical study of epilepsy drug may have been purely promotional
Yale School of Medicine researchers have found that a clinical trial of the epilepsy drug gabapentin may have been a "seeding trial" used by a pharmaceutical company to promote the drug and increase prescriptions, according ...
Medications
Jun 27, 2011 |
5 / 5 (3) |
0
|
Vascular markers linked to cognitive decline in diabetes
(HealthDay)—Stroke and subclinical markers of macrovascular disease are associated with cognitive decline in older adults with type 2 diabetes, according to a study published online April 11 in Diabetes Ca ...
Diabetes
Apr 18, 2013 |
5 / 5 (1) |
0
Some gains but many mysteries as Alzheimer's epidemic looms
More than 100 years after it was first caught in the act of decaying a patient's brain, Alzheimer's remains one of medicine's greatest challenges as it robs ever more people of their memory and independence.
Alzheimer's disease & dementia
Sep 17, 2012 |
not rated yet |
1
Sanofi earnings slashed in first quarter
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
Other
May 02, 2013 |
not rated yet |
0
Pfizer Q1 profit up, but drugmaker cuts outlook
Pfizer Inc.'s first-quarter net income rose 53 percent despite falling sales, mainly because the world's second-largest drugmaker took big charges a year ago. Pfizer's results fell short of Wall Street's ...
Other
Apr 30, 2013 |
not rated yet |
0
Studies: Alzheimer drug may stabilize brain plaque (Update)
An experimental drug that failed to stop mental decline in Alzheimer's patients in the U.S. and Canada also showed some potential benefit in slowing brain plaque, fuller results of two major studies show.
Alzheimer's disease & dementia
Sep 11, 2012 |
not rated yet |
0
Soviet-era pill from Bulgaria helps smokers quit
(AP) -- A pill developed in Bulgaria during the Soviet era shows promise for helping millions of smokers cheaply and safely kick the habit, the first big study of it shows.
Health
Sep 28, 2011 |
4.5 / 5 (2) |
0
Canada high court voids Pfizer's Viagra patent
Canada's top court on Thursday stripped Pfizer of its patent for Viagra, saying the pharmaceutical giant failed in the patent to identify the active compound in the drug.
Medications
Nov 08, 2012 |
not rated yet |
0
Hot flashes take toll on life, health, and work
Hot flashes put a damper on women's health and productivity at work and pump up the cost of health care. A study published online this month in Menopause, the journal of the North American Menopause Society (NAMS), has pu ...
Health
Feb 22, 2013 |
not rated yet |
0
Pfizer
Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. It produces Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), antibiotic Zithromax (azithromycin), Viagra (sildenafil citrate), and the anti inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside USA and Canada, mainly in South America).
Pfizer's shares were made a component of the Dow Jones Industrial Average on April 8, 2004.
On January 26, 2009, Pfizer agreed to buy pharmaceutical giant Wyeth for US$68 billion, a deal financed with cash, shares and loans.
For more information about Pfizer, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
